Alexander J. Knights

1.2k total citations · 1 hit paper
31 papers, 800 citations indexed

About

Alexander J. Knights is a scholar working on Molecular Biology, Immunology and Epidemiology. According to data from OpenAlex, Alexander J. Knights has authored 31 papers receiving a total of 800 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Immunology and 7 papers in Epidemiology. Recurrent topics in Alexander J. Knights's work include Osteoarthritis Treatment and Mechanisms (5 papers), Adipose Tissue and Metabolism (5 papers) and Adipokines, Inflammation, and Metabolic Diseases (5 papers). Alexander J. Knights is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (5 papers), Adipose Tissue and Metabolism (5 papers) and Adipokines, Inflammation, and Metabolic Diseases (5 papers). Alexander J. Knights collaborates with scholars based in United States, Australia and Canada. Alexander J. Knights's co-authors include Tristan Maerz, Merlin Crossley, Richard C. M. Pearson, Alister P. W. Funnell, Kate Quinlan, Kim Bell‐Anderson, Jun Wu, Kurt D. Hankenson, Yu‐Hua Tseng and Kyle L. Hoehn and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Alexander J. Knights

30 papers receiving 787 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inflammation in osteoarthritis: the latest progress and ongoing challenges

2022 134 citations Alexander J. Knights, Tristan Maerz et al. Current Opinion in Rheumatology profile →

Peers

Countries citing papers authored by Alexander J. Knights

Since Specialization

Citations

This map shows the geographic impact of Alexander J. Knights's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander J. Knights with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander J. Knights more than expected).

Fields of papers citing papers by Alexander J. Knights

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander J. Knights. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander J. Knights. The network helps show where Alexander J. Knights may publish in the future.

Co-authorship network of co-authors of Alexander J. Knights

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander J. Knights. A scholar is included among the top collaborators of Alexander J. Knights based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander J. Knights. Alexander J. Knights is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tirzepatide on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 trial 2025 ·Nature Medicine ·Corby K. Martin, Owen Carmichael, Susan Carnell, Robert V. Considine, David A. Kareken, Ulrike Dydak, Richard D. Mattes, David R. Scott, Sergey Shcherbinin, Hiroshi Nishiyama, Alexander J. Knights, (unknown), (unknown), Edward Pratt, Axel Haupt, Mark A. Mintun, Diana Otero Svaldi, Zvonko Miličević, Tamer Coşkun	6
2	Synovial macrophage diversity and activation of M-CSF signaling in post-traumatic osteoarthritis 2025 ·eLife ·Alexander J. Knights, (unknown), (unknown), (unknown), C. Thomas Appleton, Tristan Maerz	1
3	Transcriptomic plasticity of cholinergic adipose macrophages in the acute thermogenic response 2025 ·Journal of Biological Chemistry ·Alexander J. Knights, (unknown), Shanshan Liu, Jun Wu	0
4	Temporal dynamics of immune-stromal cell interactions in fracture healing 2024 ·Frontiers in Immunology ·(unknown), Kurt D. Hankenson, Alexander J. Knights	12
5	Signaling through the nicotinic acetylcholine receptor in the liver protects against the development of metabolic dysfunction-associated steatohepatitis 2024 ·PLoS Biology ·Heejin Jun, Shanshan Liu, Alexander J. Knights, Kezhou Zhu, Yingxu Ma, Jianke Gong, (unknown), Xiaoling Peng, (unknown), (unknown), (unknown), (unknown), Klas Kullander, Robert T. Kennedy, X.Z. Shawn Xu, Jun Wu	5
6	Association of Synovial Innate Immune Exhaustion With Worse Pain in Knee Osteoarthritis 2024 ·Arthritis & Rheumatology ·Holly T. Philpott, Trevor B. Birmingham, (unknown), (unknown), Alexander J. Knights, (unknown), Benoit Fiset, Logan A. Walsh, J. Robert Giffin, Edward M. Vasarhelyi, Steven J. MacDonald, Brent A. Lanting, Tristan Maerz, C. Thomas Appleton, (unknown)	8
7	Synovial fibroblasts assume distinct functional identities and secrete R-spondin 2 in osteoarthritis 2022 ·Annals of the Rheumatic Diseases ·Alexander J. Knights, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Eleanor Knight, (unknown), (unknown), Chia‐Lung Wu, Kurt D. Hankenson, Tristan Maerz	73
8	Inflammation in osteoarthritis: the latest progress and ongoing challenges breakdown → 2022 ·Current Opinion in Rheumatology ·Alexander J. Knights, (unknown), Tristan Maerz	134
9	Cannabinoid receptor type 2 is upregulated in synovium following joint injury and mediates anti-inflammatory effects in synovial fibroblasts and macrophages 2021 ·Osteoarthritis and Cartilage ·(unknown), (unknown), (unknown), (unknown), Samuel Goldman, Richard N. Bergman, (unknown), Alexander J. Knights, Michael R. Elliott, Tristan Maerz	36
10	Acetylcholine‐synthesizing macrophages in subcutaneous fat are regulated by β ₂ ‐adrenergic signaling 2021 ·The EMBO Journal ·Alexander J. Knights, Shanshan Liu, Yingxu Ma, (unknown), Eric Perkey, (unknown), Robert T. Kennedy, Ivan Maillard, Li Ye, Heejin Jun, Jun Wu	31
11	Adrenergic-Independent Signaling via CHRNA2 Regulates Beige Fat Activation 2020 ·Developmental Cell ·Heejin Jun, Yingxu Ma, Yong Chen, Jianke Gong, Shanshan Liu, Jine Wang, Alexander J. Knights, Xiaona Qiao, Margo P. Emont, X.Z. Shawn Xu, Shingo Kajimura, Jun Wu	31
12	Krüppel-like factor 3 (KLF3) suppresses NF-κB–driven inflammation in mice 2020 ·Journal of Biological Chemistry ·Alexander J. Knights, Lu Yang, Manan Shah, Laura J. Norton, (unknown), (unknown), (unknown), Merlin Crossley, Kate Quinlan	20
13	Eosinophil function in adipose tissue is regulated by Krüppel-like factor 3 (KLF3) 2020 ·Nature Communications ·Alexander J. Knights, (unknown), Peter J. Houweling, (unknown), Laura J. Norton, Stephanie J. Alexopoulos, (unknown), (unknown), Ellen M. Olzomer, Kim Bell‐Anderson, Kathryn N. North, Kyle L. Hoehn, Merlin Crossley, Kate Quinlan	40
14	EoTHINophils: Eosinophils as key players in adipose tissue homeostasis 2020 ·Clinical and Experimental Pharmacology and Physiology ·(unknown), (unknown), Alexander J. Knights, Kate Quinlan	16
15	Partial reprogramming of heterologous cells by defined factors to generate megakaryocyte lineage-restricted biomolecules 2018 ·Biotechnology Reports ·(unknown), Alexander J. Knights, Alister P. W. Funnell, Thomas J. Gonda, Katya Ravid, Richard C. M. Pearson, Kate Quinlan, Merlin Crossley	3
16	Krüppel-like Factor 3 (KLF3/BKLF) Is Required for Widespread Repression of the Inflammatory Modulator Galectin-3 (Lgals3) 2016 ·Journal of Biological Chemistry ·Alexander J. Knights, (unknown), (unknown), Laura J. Norton, Alister P. W. Funnell, Richard C. M. Pearson, Kim Bell‐Anderson, Merlin Crossley, Kate Quinlan	23
17	Phosphorylation of Krüppel-like Factor 3 (KLF3/BKLF) and C-terminal Binding Protein 2 (CtBP2) by Homeodomain-interacting Protein Kinase 2 (HIPK2) Modulates KLF3 DNA Binding and Activity 2015 ·Journal of Biological Chemistry ·(unknown), (unknown), Stella Lee, (unknown), (unknown), Hannah Nicholas, Kyoichi Isono, Beeke Wienert, Ka Sin Mak, Alexander J. Knights, Kate Quinlan, Stuart J. Cordwell, Alister P. W. Funnell, Richard C. M. Pearson, Merlin Crossley	22
18	Adipokines and insulin action 2014 ·Adipocyte ·Alexander J. Knights, (unknown), Richard C. M. Pearson, Merlin Crossley, Kim Bell‐Anderson	67
19	A novel MHC-associated Proteinase 3 peptide isolated from primary chronic myeloid leukaemia cells further supports the significance of this antigen for the immunotherapy of myeloid leukaemias 2006 ·Leukemia ·Alexander J. Knights, Andreas O. Weinzierl, Thomas Flad, Barbara‐ann Guinn, (unknown), G J Mufti, Stefan Stevanović, Graham Pawelec	15
20	Cancer Immunotherapy 2004: Mainz, Germany, 6?7 May 2004 2004 ·Cancer Immunology Immunotherapy ·Cedrik M. Britten, (unknown), Alexander J. Knights, Graham Pawelec	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact